📊 NHI Key Takeaways
Is NHI a Good Investment? Thesis Analysis
NHI demonstrates strong operating profitability (42.9% margin) and revenue expansion, but exhibits critical cash flow deterioration with -$57.5M FCF and minimal net income growth (+0.1%) despite 369% revenue growth, indicating acquisition-driven expansion with integration challenges. Low cash reserves ($19.6M) and modest interest coverage (2.8x) create refinancing risk in a leveraged structure.
Why Buy NHI? Key Strengths
- Exceptional operating margin of 42.9% and net margin of 37.9% indicating efficient core business operations
- Substantial operating cash flow of $236.6M providing substantial cash generation before capital deployment
- Moderate leverage with 0.77x debt-to-equity ratio and reasonable liability-to-asset mix
NHI Investment Risks to Consider
- Critical negative free cash flow of -$57.5M with capex ($294M) significantly exceeding operating cash generation, unsustainable long-term
- Dangerously low cash position of $19.6M against $1.2B debt obligations creates significant refinancing and liquidity risk
- Earnings quality deterioration: diluted EPS down 3.5% YoY and net income flat (+0.1%) despite 369% revenue growth suggests margin compression, integration costs, or acquisition-related charges
Key Metrics to Watch
- Free cash flow trajectory and cash balance trend in subsequent quarters
- Interest coverage ratio sustainability given debt load
- Net income growth recovery and operating margin stability post-acquisition
NHI Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NHI Profitability Ratios
NHI vs Default Sector
How NATIONAL HEALTH INVESTORS INC compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NHI Overvalued or Undervalued?
Based on fundamental analysis, NATIONAL HEALTH INVESTORS INC has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NHI Balance Sheet & Liquidity
NHI 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: NATIONAL HEALTH INVESTORS INC's revenue has grown significantly by 124% over the 5-year period, indicating strong business expansion. The most recent EPS of $3.13 reflects profitable operations.
NHI Growth Metrics (YoY)
NHI Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $13.8M | $28.5M | $0.65 |
| Q2 2025 | $13.4M | $35.3M | $0.79 |
| Q1 2025 | $13.3M | $30.9M | $0.71 |
| Q3 2024 | $12.4M | $28.5M | $0.65 |
| Q2 2024 | $11.8M | $35.3M | $0.81 |
| Q1 2024 | $11.7M | $30.9M | $0.71 |
| Q3 2023 | $12.0M | $29.3M | $0.68 |
| Q2 2023 | $11.8M | $21.7M | $0.47 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
NHI Capital Allocation
NHI SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for NATIONAL HEALTH INVESTORS INC (CIK: 0000877860)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NHI
What is the AI rating for NHI?
NATIONAL HEALTH INVESTORS INC (NHI) has an AI rating of HOLD with 65% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NHI's key strengths?
Claude: Exceptional operating margin of 42.9% and net margin of 37.9% indicating efficient core business operations. Substantial operating cash flow of $236.6M providing substantial cash generation before capital deployment.
What are the risks of investing in NHI?
Claude: Critical negative free cash flow of -$57.5M with capex ($294M) significantly exceeding operating cash generation, unsustainable long-term. Dangerously low cash position of $19.6M against $1.2B debt obligations creates significant refinancing and liquidity risk.
What is NHI's revenue and growth?
NATIONAL HEALTH INVESTORS INC reported revenue of $375.6M.
Does NHI pay dividends?
NATIONAL HEALTH INVESTORS INC pays dividends, with $169.7M distributed to shareholders in the trailing twelve months.
Where can I find NHI SEC filings?
Official SEC filings for NATIONAL HEALTH INVESTORS INC (CIK: 0000877860) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NHI's EPS?
NATIONAL HEALTH INVESTORS INC has a diluted EPS of $3.02.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NHI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, NATIONAL HEALTH INVESTORS INC has a HOLD rating with 65% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NHI stock overvalued or undervalued?
Valuation metrics for NHI: ROE of 9.3% (sector avg: 15%), net margin of 37.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NHI stock in 2026?
Our dual AI analysis gives NATIONAL HEALTH INVESTORS INC a combined HOLD rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is NHI's free cash flow?
NATIONAL HEALTH INVESTORS INC's operating cash flow is $236.6M, with capital expenditures of $294.0M. FCF margin is -15.3%.
How does NHI compare to other Default stocks?
Vs Default sector averages: Net margin 37.9% (avg: 12%), ROE 9.3% (avg: 15%), current ratio N/A (avg: 1.8).